Loading...

About Oxford Biomedica

Overview

Pipeline

We are working on several internal product candidates and have interests in an expanding range of partner programmes

Bioprocessing

Our bioprocessing expertise and facilities support both our own and our partners’ product development

Press releases

Oxford Biomedica notes AstraZeneca’s COVID-19 vaccine has been authorised for emergency supply in the UK

30 December 2020

John Dawson named Executive of the Year for Companies <$10bn at the Annual Scrip Awards 2020

03 December 2020

Oxford Biomedica notes AstraZeneca’s AZD1222 met primary efficacy endpoint in preventing COVID-19

23 November 2020

More press releases

Share price

See full chart

Latest annual report

default image

Go to downloads